Patent classifications
C07F9/28
BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS
Gold (I) complexes that can absorb light in the near-UV and/or visible regions and methods of making and using thereof are described. These gold (I) complexes have photochemical reactivities, such as strong absorption of near-UV and/or visible light, quenching rate constants ≥3.5×10.sup.5 s.sup.−1, etc., that allow them to catalyze photoredox reactions, such as homocoupling of organic halides (e.g. alkyl halides and aryl halides), alkylation of 2-phenyl-1,2,3,4-tetrahydroisoquinoline, cyclization of indoles, reductive dehalogenation of aryl halides, and/or C—H bonds cleavage, under near-UV and/or visible light. The product of a photo-induced organic reaction catalyzed by the gold (I) complexes described herein can have a yield that is higher than the yield of the same product formed from the same reaction under the same reaction conditions, using the same loading or a higher loading of [Au.sub.2(μ-dppm).sub.2](Cl).sub.2, [Ru(bpy).sub.3](Cl).sub.2, and/or [fac-Ir(ppy).sub.3] compared to the loading of the one or more gold (I) complex(es).
BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS
Gold (I) complexes that can absorb light in the near-UV and/or visible regions and methods of making and using thereof are described. These gold (I) complexes have photochemical reactivities, such as strong absorption of near-UV and/or visible light, quenching rate constants ≥3.5×10.sup.5 s.sup.−1, etc., that allow them to catalyze photoredox reactions, such as homocoupling of organic halides (e.g. alkyl halides and aryl halides), alkylation of 2-phenyl-1,2,3,4-tetrahydroisoquinoline, cyclization of indoles, reductive dehalogenation of aryl halides, and/or C—H bonds cleavage, under near-UV and/or visible light. The product of a photo-induced organic reaction catalyzed by the gold (I) complexes described herein can have a yield that is higher than the yield of the same product formed from the same reaction under the same reaction conditions, using the same loading or a higher loading of [Au.sub.2(μ-dppm).sub.2](Cl).sub.2, [Ru(bpy).sub.3](Cl).sub.2, and/or [fac-Ir(ppy).sub.3] compared to the loading of the one or more gold (I) complex(es).
COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
The present specification relates to a compound represented by Chemical Formula 1, and an organic light emitting device including the same.
COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
The present specification relates to a compound represented by Chemical Formula 1, and an organic light emitting device including the same.
Method for forming silicon-phosphorous materials
Embodiments generally relate to methods for depositing silicon-phosphorous materials, and more specifically, relate to using silicon-phosphorous compounds in vapor deposition processes (e.g., epitaxy, CVD, or ALD) to deposit silicon-phosphorous materials. In one or more embodiments, a method for forming a silicon-phosphorous material on a substrate is provided and includes exposing the substrate to a deposition gas containing one or more silicon-phosphorous compounds during a deposition process and depositing a film containing the silicon-phosphorous material on the substrate. The silicon-phosphorous compound has the chemical formula [(R.sub.3-vH.sub.vSi)—(R.sub.2-wH.sub.wSi).sub.n].sub.xPH.sub.yR′.sub.z, where each instance of R and each instance of R′ are independently an alkyl or a halogen, n is 0, 1, or 2; v is 0, 1, 2, or 3; w is 0, 1, or 2; x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2, and where x+y+z=3.
SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME
The present specification provides a compound having a spiro structure of Chemical Formula 1, and an organic light emitting device including the same.
SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME
The present specification provides a compound having a spiro structure of Chemical Formula 1, and an organic light emitting device including the same.
Compounds for inhibiting cell proliferation in EGFR-driven cancers
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula I: ##STR00001##
wherein the variables are as defined herein.
Compounds for inhibiting cell proliferation in EGFR-driven cancers
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula I: ##STR00001##
wherein the variables are as defined herein.
Ligand compound, catalyst system for olefin oligomerization, and olefin oligomerization method using the same
The present invention relates to a ligand compound, a catalyst system for olefin oligomerization, and a method for olefin oligomerization using the same. The present ligand compound is a compound having a certain new structure and enables provision of a catalyst system for olefin oligomerization that can oligomerize ethylene with higher catalytic activity.